Have any thoughts about
Medibio Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

-68.1
Current
-68.1
Median
17.1
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-68.1
=
Enterprise Value
121.8m AUD
/
EBIT
-1.8m AUD
All Countries
Close
EBIT Growth EV/EBIT to Growth
AU
Medibio Ltd
ASX:MEB
Average EV/EBIT: 520.5
Negative Multiple: -68.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
47.3
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
220.8
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.9
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
70.2
N/A N/A
JP
M3 Inc
TSE:2413
13.8
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
383.1
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.1 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 823.9
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32
123%
0.3

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A

See Also

Discover More